After reading about Interleukin-12 online it seems its primary use has been for Cancer Tumors. Our use of Interleukin-12 is for our MS Provisional Patent application, So I'm wondering if this is one of the connections scientifically that drew the highly esteemed Ellen S. Vitetta, Ph.D.to our advisory board due to her work with Interleukin-4 which is anti-Cancer and her work also with B-Cells, which might have interested her in our CLONE3 MaBs B-Cell lines focus. Also, WILL another Provisional Patent be applied for a re-combatant use combining CLONE3,ITV-1 and Interleukin-12 for Cancer? I think with the combining of our 2 Companies and with the assembling of this incredibly talented Advisory Board are telltale signs of GREAT things to come in "21". The more I research, the more confident I become.
AI
Market Data 
Markets 
